|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 | |||
| A61K 31/712 |
| (11) | Number of the document | 2458006 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11189591.8 |
| Date of filing the European patent application | 2007-05-07 | |
| (97) | Date of publication of the European application | 2012-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 746631 P | 2006-05-05 | US | |
| 747059 P | 2006-05-11 | US | |
| 805660 P | 2006-06-23 | US | |
| 864554 P | 2006-11-06 | US | |
| PCT/US2007/0611 | 2007-01-27 | WO |
| (72) |
Bhanot, Sanjay, US
Geary, Richard S., US
McKay, Robert, US
Monia, Brett P., US
Seth, Punit P., US
Siwkowski, Andrew M., US
Swayze, Eric E., US
Wancewicz, Edward, US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | Compounds and methods for modulating expression APOB |
| Compounds and methods for modulating expression APOB |